D-1094-2023 Class III Terminated

Recalled by Imprimis NJOF, LLC — Ledgewood, NJ

Recall Details

Product Type
Drugs
Report Date
August 30, 2023
Initiation Date
August 10, 2023
Termination Date
January 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,683 bottles

Product Description

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

Reason for Recall

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

Distribution Pattern

Nationwide in the US

Code Information

Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23.